Product NDC: | 68258-8961 |
Proprietary Name: | SEREVENT |
Non Proprietary Name: | salmeterol xinafoate |
Active Ingredient(s): | 50 ug/1 & nbsp; salmeterol xinafoate |
Administration Route(s): | ORAL; RESPIRATORY (INHALATION) |
Dosage Form(s): | POWDER, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68258-8961 |
Labeler Name: | Dispensing Solutions, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020692 |
Marketing Category: | NDA |
Start Marketing Date: | 19971125 |
Package NDC: | 68258-8961-6 |
Package Description: | 60 POWDER, METERED in 1 INHALER (68258-8961-6) |
NDC Code | 68258-8961-6 |
Proprietary Name | SEREVENT |
Package Description | 60 POWDER, METERED in 1 INHALER (68258-8961-6) |
Product NDC | 68258-8961 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | salmeterol xinafoate |
Dosage Form Name | POWDER, METERED |
Route Name | ORAL; RESPIRATORY (INHALATION) |
Start Marketing Date | 19971125 |
Marketing Category Name | NDA |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | SALMETEROL XINAFOATE |
Strength Number | 50 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |